Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

Founded in 2011, Elicio Therapeutics Inc. ELTX has made several significant strides in the last 13 years. The immunotherapy company has completed multiple successful preclinical trials and has been featured in publications like Nature Medicine and Cancer Immunology Research, a journal of the…#eliciotherapeutics #amp #eli002 #kras #cpg #grandviewresearch #trialinprogress #amplify7p #eli0027p #pdac
Source: Reuters: Health - Category: Consumer Health News Source Type: news